Key Takeaways
- The Orioles traded Bryan Baker to the Rays for a 2025 compensatory draft pick and used that pick (plus cash) to acquire controllable starter Shane Baz—an objectively solid return.
- Baker’s transformation into an All‑Star closer is largely attributable to the Rays’ advanced pitching development system; the Orioles would likely have seen him remain a mid‑to‑high‑3 ERA reliever had he stayed in Baltimore.
- The Orioles have a history of turning low‑cost relievers into productive assets (e.g., Danny Coulombe, Yennier Cano) and of benefitting when former Baltimore arms flourish elsewhere (e.g., Eduard Bazardo).
- The real mistake was not the Baker‑for‑pick trade itself, but the Orioles’ failure to rebuild their bullpen after moving multiple relievers at the 2023 deadline, opting instead for unproven arms rather than pursuing additional low‑cost, high‑upside bullpen projects.
- Controllable starting pitching remains a premium asset; using Baker as trade bait to secure Shane Baz (signed through 2026 with a two‑year extension) was a sound strategic move for Baltimore.
When the Baltimore Orioles claimed Bryan Baker off waivers from the Toronto Blue Jays, he appeared to be a typical reclamation project: a right‑handed reliever with one MLB inning under his belt, destined for organizational depth. Over the next four seasons Baker became a regular piece of the Orioles’ bullpen, flashing moments of dominance—sometimes looking like one of their best relief arms—while also enduring stretches of inconsistency that sent him back to Triple‑A for refinement.
By the 2023 season, with the Orioles out of playoff contention early and Baker posting solid numbers, Baltimore decided to move him. The Rays offered a 2025 compensatory draft pick, a price the Orioles could not refuse given Baker’s dwindling options and the team’s need to restock its farm system. The trade was completed, and Baltimore received the pick (along with some cash) that would later be used in a separate deal with Tampa Bay.
Almost a year later, Baker has emerged as the Rays’ trusted closer and earned an All‑Star selection, while the Orioles’ bullpen ranks among the worst in the league. At first glance, the trade looks like a catastrophic misstep: Baltimore gave away a pitcher who is now excelling elsewhere. However, a deeper look reveals that the Orioles did not misjudge Baker’s talent; they misjudged the context in which that talent could flourish.
The Rays possess one of the most sophisticated pitching development infrastructures in baseball. Their staff routinely tweaks mechanics, pitch mixes, and usage patterns to unlock latent potential in relievers. Bryan Baker’s jump from a mid‑to‑high‑3 ERA arm in Baltimore to an elite closer in Tampa Bay is consistent with that pattern: the Rays took a solid but unspectacular reliever and turned him into a high‑leverage weapon. Had Baker remained in Baltimore, the Orioles’ player development and coaching staff—while competent—would likely have produced similar results to what he delivered for most of his tenure: a reliable, but not dominant, middle‑relief option.
This phenomenon is not unique to the Orioles. Clubs across the league constantly harvest inexpensive relievers, attempt mechanical or pitch‑selection adjustments, and hope to produce an elite arm. Baltimore itself has benefited from this approach: the Twins deals that brought Danny Coulombe and Yennier Cano yielded years of above‑average production, and the organization has often seen former Baltimore pitchers—such as Eduard Bazardo with the Mariners—thrive after leaving. The frequency of such outcomes means that front offices cannot afford to dwell on every reliever who improves elsewhere; the market simply rewards the process of acquiring low‑cost, projectable arms and developing them.
From a purely transactional standpoint, the Orioles extracted good value from the Baker trade. Sending a reliever with limited options for a compensatory pick is a sound move, especially when that pick is later flipped for a controllable starter. The Orioles used that pick (plus cash) to acquire Shane Baz from the Rays, securing three years of team‑controlled starting pitching and subsequently extending him for two more seasons. Starting pitching remains one of the most coveted commodities in trades, and Baltimore’s inability to attract such talent through free agency made the Baz acquisition a strategic win.
The real error arrived after the Orioles dealt not only Baker but also several other relievers—Seranthony Domínguez, Gregory Soto, and Andrew Kittredge—at the 2023 deadline. Facing a depleted bullpen, the club needed to replicate the successful “Baker model” multiple times: identify inexpensive arms with track records, then apply developmental tweaks to unlock elite performance. Instead, the front office filled the void with a collection of pitchers lacking significant MLB experience, hoping raw talent alone would suffice. This approach neglected the proven pipeline that had previously turned low‑cost relievers into valuable contributors and left the bullpen without the depth needed to compete.
In summary, the Orioles’ trade of Bryan Baker was not a mistake; it was a logical, value‑driven decision that yielded a high‑quality starting pitcher in Shane Baz. The Orioles’ subsequent failure to reinvest in their bullpen with the same low‑cost, high‑upside strategy represents the true misstep. Moving forward, Baltimore would benefit from revisiting the formula that turned Danny Coulombe, Yennier Cano, and now Bryan Baker into productive assets: target inexpensive relievers with demonstrable track records, apply targeted development, and repeat the process until the bullpen is rebuilt. Until then, the contrast between Baker’s All‑Star success in Tampa Bay and Baltimore’s struggling relief corps will remain a cautionary tale about the importance of process over isolated transactions.